Legal Representation
Attorney
Elizabeth D. Lewen
USPTO Deadlines
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 21, 2016 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Aug 31, 2016 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Sep 3, 2014 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Jul 23, 2014 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Feb 1, 2012 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Jul 7, 2008 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Jul 7, 2008 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Dec 10, 2007 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Dec 10, 2007 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Dec 10, 2007 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Nov 30, 2007 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 30, 2007 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 30, 2007 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 31, 2007 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| May 31, 2007 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 31, 2007 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 31, 2007 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 31, 2007 | ALIE | A | ASSIGNED TO LIE | Loading... |
| May 14, 2007 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 29, 2007 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 29, 2007 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 29, 2007 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 8, 2006 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
pharmaceutical preparations for the treatment of immune system disorders; pharmaceutical preparations for regulation of the immune system
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005